Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Consolidated Balance Sheets (Parentheticals)

v3.25.4
Consolidated Balance Sheets (Parentheticals)
 12 Months Ended
Dec. 31, 2025
USD ($)
shares
Statement of Financial Position [Abstract]  
Accounts Receivable, Allowance for Credit Loss $ 4,145,000
Ordinary shares, authorized | shares 180,000,000
Document Period End Date Dec. 31, 2025
Cash and cash equivalents $ 94,527,000
Short-term bank deposits 150,000,000
Accounts receivable, net of allowance for credit losses of $0.9 million and $0.5 million as of December 31, 2022 and December 31, 2021, respectively 160,478,000
Inventories 145,238,000
Prepaid expenses 5,500,000
Other current assets 26,241,000
Assets, Current 581,984,000
Property, plant and equipment, net 192,566,000
Goodwill 101,599,000
Other intangible assets, net 95,842,000
Operating lease right-of-use assets 25,417,000
Long-term investments 63,104,000
Other non-current assets 13,252,000
Assets, Noncurrent 491,780,000
Assets 1,073,764,000
Accounts payable 43,021,000
Accrued expenses and other current liabilities 34,284,000
Accrued compensation and related benefits 31,304,000
Deferred revenues - short-term 47,835,000
Operating lease liabilities - short term 6,597,000
Liabilities, Current 163,041,000
Deferred revenues - long-term 19,062,000
Deferred income taxes 312,000
Operating lease liabilities - long term 19,903,000
Contingent consideration 5,353,000
Other non-current liabilities $ 23,193,000
Shares, Outstanding | shares 86,110,000
Shares, Issued | shares 86,376,000